Defra Unveils Further Bovine TB Test Improvements, USA
Main Category: TuberculosisAlso Included In: Veterinary
Article Date: 12 Aug 2006 - 15:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Animal Health and Welfare Minister Ben Bradshaw has today announced further action to enhance testing for bovine tuberculosis (TB) in cattle.
These new measures include:
-- details of how the gamma interferon blood test will be used more extensively alongside the skin test to improve the sensitivity of the testing regime and speed up the identification of more infected animals;
-- a report on Bovine TB testing procedures in England and Wales, and;
-- the conclusions of the Chief Veterinary Officer's review into the fall in the number of new TB incidents in Great Britain.
"Our cattle testing programme is a crucial part of our efforts to reduce bovine TB," said Mr Bradshaw. "The tuberculin test is, and will remain, central to TB cattle controls, but we can improve our testing regime by making greater use of the gamma interferon blood test.
"Therefore, from October we will treble the number of gamma interferon tests that are carried out and target them on those herds where they will deliver the greatest impact," he said.
"The tuberculin test is effective when carried out properly. DNV Consulting's report on our current procedures provides welcome assurance about the overall effectiveness of the national testing programme. However, some of the evidence about the degree to which individuals depart from testing procedures highlights a need for corrective action.
"The State Veterinary Service will be reviewing existing training procedures and tightening up the management of both its own staff and private vets contracted to carry out TB testing. I would urge the veterinary profession to work with us to raise the standard of TB testing in GB."
Details of how the gamma interferon blood test for bovine TB will be introduced across England and Wales from October are available below.
Chief Veterinary Officer Debby Reynolds was asked by Mr Bradshaw in June to undertake a review of the apparent fall in the number of new TB incidents. She has concluded that there has been a real reduction in the number of new TB incidents, but that it is too early to determine whether this is a temporary phenomenon or likely to become a sustained trend.
Dr Reynolds has considered whether the switch in tuberculin supply from that manufactured by the Veterinary Laboratories Agency to that purchased from Holland could have caused this reduction.
She has concluded that the small difference in performance between the two tuberculins is not significant enough on its own to have had such a significant impact, particularly against the background of the evidence in the DNV Consulting report about the variation in the way the test is carried out.
Further analysis will be carried out to try to reduce the level of uncertainty around these conclusions.
-- Gamma interferon research
-- DNV Consulting's review
-- Debby Reynolds' report
Visit our tuberculosis section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/49460.php>
APA
http://www.medicalnewstoday.com/releases/49460.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



